Healthcare
SQ Innovation
Recorded May 22, 2025
SQ Innovation has developed a novel drug-device combination for treating fluid overload in adult patients with chronic heart failure
SQ Innovation has developed a novel drug-device combination for treating fluid overload in adult patients with chronic heart failure
Cellibre has developed a platform technology to produce chemicals creating less expensive, higher quality, and more resilient supply chains.
AcuamarkDX has developed a blood-based cancer detection platform for all stage 1 and 2 cancers where survival rates are highest.
AcuamarkDX has developed a blood-based cancer detection platform for all stage 1 and 2 cancers where survival rates are highest.
Adora Life Science is unlocking the potential of a drug that stimulates cartilage repair and can slow the progression of degenerative joint disease.
NeuroVision’s AI-driven BrainHealth Platform is redefining how we prevent, diagnose, and treat Alzheimer’s and other neurological conditions
Adora Life Science is unlocking the potential of a drug that stimulates cartilage repair and can slow the progression of degenerative joint disease.
NeuroVision’s AI-driven BrainHealth Platform is redefining how we prevent, diagnose, and treat Alzheimer’s and other neurological conditions
Sigyn Therapeutics [OTCQB: SIGY] is a pioneering developer of medical devices targeting cancer, infectious diseases, and more
Sigyn Therapeutics [OTCQB: SIGY] is a pioneering developer of medical devices targeting cancer, infectious diseases, and more
Cellibre has developed a platform technology to produce chemicals creating less expensive, higher quality, and more resilient supply chains.
Cellibre has developed a platform technology to produce chemicals creating less expensive, higher quality, and more resilient supply chains.